Oral Expectorant Market Size & Share, Growth Analysis 2024-2032

Oral Expectorant Market – By Drug Type (Secretion Enhancer [Potassium Citrate Ammonium Chloride], Mucolytics), Dosage Form (Solid, Liquid, Inhalant), Medication (Prescription, OTC), Distribution Channel (Hospital, Online, Retail) – Global Forecast (2024 ­ 2032)

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Increasing prevalence of respiratory disease

3.2.1.2&nbsp;&nbsp;&nbsp; Growing demand for OTC medications

3.2.1.3&nbsp;&nbsp;&nbsp; Rising geriatric population

3.2.1.4&nbsp;&nbsp;&nbsp; Increasing awareness among people about respiratory conditions

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Strict government and regulatory guidelines

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Pipeline analysis

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Company market share analysis

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Strategic dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Drug Type, 2021 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Secretion enhancer

5.2.1&nbsp;&nbsp;&nbsp; Potassium citrate

5.2.2&nbsp;&nbsp;&nbsp; Potassium iodide

5.2.3&nbsp;&nbsp;&nbsp; Sodium citrate

5.2.4&nbsp;&nbsp;&nbsp; Guaiphenesin

5.2.5&nbsp;&nbsp;&nbsp; Ammonium chloride

5.2.6&nbsp;&nbsp;&nbsp; Other secretion enhancer

5.3&nbsp;&nbsp;&nbsp; Mucolytics

5.3.1&nbsp;&nbsp;&nbsp; Bromhexine

5.3.2&nbsp;&nbsp;&nbsp; Ambroxol

5.3.3&nbsp;&nbsp;&nbsp; Acetyl cysteine

5.3.4&nbsp;&nbsp;&nbsp; Carbocisteineurine

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Dosage Form, 2021 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Oral solids

6.2.1&nbsp;&nbsp;&nbsp; Powder &amp; granules

6.2.2&nbsp;&nbsp;&nbsp; Tablet

6.2.3&nbsp;&nbsp;&nbsp; Capsule

6.3&nbsp;&nbsp;&nbsp; Oral liquids

6.3.1&nbsp;&nbsp;&nbsp; Syrup

6.3.2&nbsp;&nbsp;&nbsp; Solution

6.3.3&nbsp;&nbsp;&nbsp; Suspension

6.4&nbsp;&nbsp;&nbsp; Inhalants

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Medication, 2021 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Prescription drugs

7.3&nbsp;&nbsp;&nbsp; Over-the-counter drugs

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Distribution Channel, 2021 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Hospital pharmacies

8.3&nbsp;&nbsp;&nbsp; Retail store &amp; drug store

8.4&nbsp;&nbsp;&nbsp; Online pharmacies

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2032 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends, by region

9.2&nbsp;&nbsp;&nbsp; North America

9.2.1&nbsp;&nbsp;&nbsp; U.S.

9.2.2&nbsp;&nbsp;&nbsp; Canada

9.3&nbsp;&nbsp;&nbsp; Europe

9.3.1&nbsp;&nbsp;&nbsp; Germany

9.3.2&nbsp;&nbsp;&nbsp; UK

9.3.3&nbsp;&nbsp;&nbsp; France

9.3.4&nbsp;&nbsp;&nbsp; Spain

9.3.5&nbsp;&nbsp;&nbsp; Italy

9.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

9.4&nbsp;&nbsp;&nbsp; Asia Pacific

9.4.1&nbsp;&nbsp;&nbsp; Japan

9.4.2&nbsp;&nbsp;&nbsp; China

9.4.3&nbsp;&nbsp;&nbsp; India

9.4.4&nbsp;&nbsp;&nbsp; Australia

9.4.5&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

9.5&nbsp;&nbsp;&nbsp; Latin America

9.5.1&nbsp;&nbsp;&nbsp; Brazil

9.5.2&nbsp;&nbsp;&nbsp; Mexico

9.5.3&nbsp;&nbsp;&nbsp; Rest of Latin America

9.6&nbsp;&nbsp;&nbsp; Middle East and Africa

9.6.1&nbsp;&nbsp;&nbsp; South Africa

9.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

9.6.3&nbsp;&nbsp;&nbsp; Rest of Middle East and Africa

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles

10.1&nbsp;&nbsp;&nbsp; Abbott Laboratories

10.2&nbsp;&nbsp;&nbsp; AstraZeneca

10.3&nbsp;&nbsp;&nbsp; Cipla Inc.

10.4&nbsp;&nbsp;&nbsp; Genexa Inc.

10.5&nbsp;&nbsp;&nbsp; GlaxoSmithKline (GSK) plc

10.6&nbsp;&nbsp;&nbsp; Merck KGaA

10.7&nbsp;&nbsp;&nbsp; Perrigo Company plc

10.8&nbsp;&nbsp;&nbsp; Reckitt Benckiser Group PLC

10.9&nbsp;&nbsp;&nbsp; Sanofi

10.10&nbsp;&nbsp;&nbsp; Sun Pharmaceutical Industries Ltd.

10.11&nbsp;&nbsp;&nbsp; The Himalaya Drug Company 
&nbsp;

Oral Expectorant Market

Get a free sample of this report